Fig. 7: A hypothesis model depicting that TKI treatment increased the expression of TRIM15 by inhibiting the AKT/FOXO1 axis in HCC.

The upregulated TRIM15 contributed to TKI resistance by promoting the ubiquitination and nuclear localization of LASP1, which activated the AKT signaling pathway and increased the snail expression in HCC.